LRP8 is a receptor for tick-borne encephalitis virus
Eva Mittler1, Alexandra L Tse2, Pham-Tue-Hung Tran3
1Department of Microbiology and Immunology, Albert Einstein College of Medicine, New York, NY, USA. eva-maria.mittler@einsteinmed.edu.
Abstract:
Tick-borne encephalitis virus (TBEV) causes tick-borne encephalitis (TBE), a severe and sometimes life-threatening disease characterized by viral invasion of the central nervous system with symptoms of neuroinflammation1,2. As with other orthoflaviviruses-enveloped, arthropod-borne RNA viruses-host factors required for TBEV entry remain poorly defined. Here we used a genome-scale CRISPR-Cas9-based screen to identify LRP8, an apolipoprotein E and reelin receptor with high expression in the brain, as a TBEV receptor. LRP8 downregulation reduced TBEV infection in human cells, and its overexpression enhanced infection. LRP8 bound directly to the TBEV E glycoprotein and mediated viral attachment and internalization into cells. An LRP8-based soluble decoy blocked infection of human cell lines and neuronal cells and protected mice from lethal TBEV challenge. LRP8's role as a TBEV receptor has implications for TBEV neuropathogenesis and the development of antiviral countermeasures.
Insights
Researchers identified LRP8 as a key receptor for tick-borne encephalitis virus (TBEV) entry into cells. Blocking LRP8 protected human cells and mice from TBEV infection, offering new therapeutic strategies.
Area of Science:
- Virology
- Neuroscience
- Immunology
Background:
- Tick-borne encephalitis virus (TBEV) causes severe neuroinflammation and is a significant public health concern.
- Host factors mediating TBEV entry into the central nervous system are not well understood.
- Orthoflaviviruses, like TBEV, are enveloped RNA viruses transmitted by arthropods.
Purpose of the Study:
- To identify host factors essential for TBEV entry and infection.
- To investigate the role of identified factors in viral neuropathogenesis.
- To explore potential therapeutic targets for TBEV infection.
Main Methods:
- Genome-scale CRISPR-Cas9 screening was employed to identify host cell receptors for TBEV.
- LRP8 function in TBEV infection was assessed through downregulation and overexpression studies in human cells.
- Direct binding assays between LRP8 and the TBEV E glycoprotein were performed.
- Viral attachment and internalization mediated by LRP8 were analyzed.
- An LRP8-based soluble decoy was developed and tested for antiviral efficacy in cell lines, neuronal cells, and a mouse model.
Main Results:
- LRP8, a receptor for apolipoprotein E and reelin, was identified as a critical TBEV receptor.
- Downregulation of LRP8 significantly reduced TBEV infection, while its overexpression enhanced it.
- LRP8 directly binds to the TBEV E glycoprotein, facilitating viral attachment and cell entry.
- An LRP8-based soluble decoy effectively blocked TBEV infection in various cell types and protected mice from lethal challenge.
Conclusions:
- LRP8 is a crucial host factor for TBEV entry, mediating viral attachment and internalization.
- Targeting LRP8 presents a promising strategy for developing novel antiviral therapies against TBEV.
- Understanding LRP8's role advances knowledge of TBEV neuropathogenesis and potential treatment avenues.
More Related Videos
Related Concept Videos
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Arboviral Encephalitis
Encephalitis l: Introduction
Encephalitis ll: Pathophysiology


